Neuroleptic malignant syndrome and atypical antipsychotic drugs.

@article{Ananth2004NeurolepticMS,
  title={Neuroleptic malignant syndrome and atypical antipsychotic drugs.},
  author={J. Ananth and S. Parameswaran and S. Gunatilake and K. Burgoyne and Taghrid Sidhom},
  journal={The Journal of clinical psychiatry},
  year={2004},
  volume={65 4},
  pages={
          464-70
        }
}
OBJECTIVE The incidence of neuroleptic malignant syndrome (NMS) is not known, but the frequency of its occurrence with conventional antipsychotic agents has been reported to vary from 0.02% to 2.44%. DATA SOURCES MEDLINE search conducted in January 2003 and review of references within the retrieved articles. DATA SYNTHESIS Our MEDLINE research yielded 68 cases (21 females and 47 males) of NMS associated with atypical antipsychotic drugs (clozapine, N = 21; risperidone, N = 23; olanzapine, N… Expand
223 Citations
Clozapine-induced neuroleptic malignant syndrome in an adolescent.
  • K. Matheson, G. Gray
  • Psychology, Medicine
  • Journal of child and adolescent psychopharmacology
  • 2012
Olanzapine-Induced Neuroleptic Malignant Syndrome
Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 79 REFERENCES
Risperidone-Induced Neuroleptic Malignant Syndrome: A Case Report and Review
  • G. Meterissian
  • Psychology, Medicine
  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 1996
Neuroleptic malignant syndrome associated with clozapine treatment.
Risperidone and neuroleptic malignant syndrome.
Clinical Management of Neuroleptic Malignant Syndrome
...
1
2
3
4
5
...